 Home > Medical News > Medicines Company News > Oculis, an ophthalmic biopharmaceutical company, has over-completed Series C financing, and Baiao Wealth and Huiding Investment jointly led the investment

Oculis, an ophthalmic biopharmaceutical company, has over-completed Series C financing, and Baiao Wealth and Huiding Investment jointly led the investment

 Last Update: 2021-07-07
 Source: Internet
 Author: User

Tags

life skin cell

conditioning treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Oculis announced that it has over-completed its Series C financing
.

Oculis is a biopharmaceutical company focused on the clinical stage, which improves the vision and living standards of patients through the development of new ophthalmic treatments

This round of financing aims to promote shareholder value and bring innovative ophthalmic drugs to patients
.

With the help of this round of financing, Oculis will be able to accelerate the development of topical drug preparations for retinal and anterior ocular diseases, and achieve key short-term goals, including: promoting the development of Oculis's innovative series of topical ophthalmic drugs in the clinical phase; To meet the needs of ophthalmology treatment, Oculis continues to expand the candidate drug products of innovative ophthalmic preparations by virtue of its advantages such as its patented formulation platform; develop Oculis's international strategy, with the mission of improving the vision and life of patients around the world, and actively research and develop pioneering ophthalmology Treatment solutions have become a strong participant in the global ophthalmic pharmaceutical market

After the completion of this round of financing, Baiao Wealth Management Partner Huang Yifei and Huiding Investment Management Partner Dr.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.